Free Trial

Acumen Pharmaceuticals (ABOS) Short Interest Ratio & Short Volume

Acumen Pharmaceuticals logo
$1.79 +0.02 (+1.13%)
(As of 12/24/2024 02:54 PM ET)

Acumen Pharmaceuticals Short Interest Data

Acumen Pharmaceuticals (ABOS) has a short interest of 1.39 million shares, representing 3.09% of the float (the number of shares available for trading by the public). This marks a -5.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.9, indicating that it would take 6.9 days of the average trading volume of 326,806 shares to cover all short positions.

Current Short Interest
1,390,000 shares
Previous Short Interest
1,470,000 shares
Change Vs. Previous Month
-5.44%
Dollar Volume Sold Short
$3.16 million
Short Interest Ratio
6.9 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
60,080,000 shares
Float Size
45,030,000 shares
Short Percent of Float
3.09%
Today's Trading Volume
363,191 shares
Average Trading Volume
326,806 shares
Today's Volume Vs. Average
111%
Short Selling Acumen Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ABOS Short Interest Over Time

ABOS Days to Cover Over Time

ABOS Percentage of Float Shorted Over Time

Acumen Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/20241,390,000 shares $3.16 million -5.4%3.1%6.9 $2.27
11/15/20241,470,000 shares $3.53 million +1.4%3.3%7.6 $2.40
10/31/20241,450,000 shares $4.18 million +14.2%3.2%7.8 $2.88
10/15/20241,270,000 shares $2.96 million -18.6%2.8%6.3 $2.33
9/30/20241,560,000 shares $3.87 million -7.7%3.5%6.1 $2.48
9/15/20241,690,000 shares $4.39 million No Change3.8%4.5 $2.60
8/31/20241,690,000 shares $4.63 million -8.7%3.8%4.2 $2.74
8/15/20241,850,000 shares $4.76 million -1.1%4.1%4.3 $2.58
7/31/20241,870,000 shares $6.17 million +12.7%4.2%4.4 $3.30
7/15/20241,660,000 shares $4.81 million +67.6%3.7%4 $2.90
6/30/2024990,400 shares $2.40 million +39.4%2.2%2.7 $2.42
6/15/2024710,600 shares $1.88 million +0.4%1.6%2.4 $2.64
5/31/2024707,800 shares $2.08 million -13.3%1.6%2.6 $2.94
5/15/2024816,000 shares $3.10 million -12.0%1.8%2.7 $3.80
4/30/2024926,900 shares $2.98 million -11.7%2.1%2.9 $3.22
4/15/20241,050,000 shares $3.71 million -15.3%2.4%3.1 $3.53
3/31/20241,240,000 shares $5.02 million +21.6%2.9%3.4 $4.05
3/15/20241,020,000 shares $4.26 million +31.9%2.5%2.5 $4.18
2/29/2024773,400 shares $3.33 million +13.8%1.9%1.8 $4.31
2/15/2024679,700 shares $2.13 million -7.2%1.6%1.6 $3.13
1/31/2024732,100 shares $2.33 million +4.7%1.9%1.5 $3.18
1/15/2024699,400 shares $2.71 million +53.7%1.8%1.3 $3.88
12/31/2023455,200 shares $1.75 million -25.3%1.1%0.8 $3.84
12/15/2023609,600 shares $1.76 million +13.3%1.5%1.2 $2.88
11/30/2023538,300 shares $1.29 million +3.6%1.3%1.1 $2.40
11/15/2023519,500 shares $1.23 million -35.1%1.3%1.1 $2.37
10/31/2023800,000 shares $1.50 million -60.8%1.8%1.8 $1.87
10/15/20232,040,000 shares $7.63 million -1.0%4.6%4.6 $3.74
9/30/20232,060,000 shares $8.55 million +17.1%4.7%1.8 $4.15
9/15/20231,760,000 shares $9.73 million +0.6%4.0%1.6 $5.53
8/31/20231,750,000 shares $10.54 million +8.0%4.0%1.6 $6.02
8/15/20231,620,000 shares $11.53 million +4.5%3.7%1.5 $7.12
7/31/20231,550,000 shares $11.47 million +154.0%3.5%1.5 $7.40
7/15/2023610,200 shares $3.83 million +218.8%1.6%0.6 $6.28
6/30/2023191,400 shares $920,634.00 +26.8%0.7%0.7 $4.81
6/15/2023151,000 shares $847,110.00 -37.1%0.5%0.8 $5.61
5/31/2023240,200 shares $1.18 million +50.3%0.9%1.3 $4.93
5/15/2023159,800 shares $990,760.00 -26.3%0.6%0.9 $6.20
4/30/2023216,800 shares $836,848.00 -63.2%0.8%1.5 $3.86
4/15/2023589,700 shares $2.21 million -1.5%2.1%5.9 $3.74
A brand new opportunity in the stock market revealed (Ad)

Today, I want to unlock a brand new opportunity in the stock market… One that has been able to pay out around 100% in 5 days or less so far on REAL money… It’s all thanks to a hidden force that drives some of the BIGGEST & most repetitive moves in stocks… I call it a Gamma Pocket…

Will you be the next trader to discover the power of Gamma Pockets?
3/31/2023598,400 shares $2.43 million -3.2%2.2%6.5 $4.06
3/15/2023618,000 shares $2.54 million -2.5%2.2%7.6 $4.11
2/28/2023634,100 shares $3.34 million +6.2%2.3%7.8 $5.27
2/15/2023597,000 shares $3.36 million -2.1%2.2%6.7 $5.62
1/31/2023609,900 shares $4.01 million +1.0%2.0%6 $6.57
1/15/2023603,600 shares $3.77 million +5.6%2.1%5.4 $6.24
12/30/2022571,700 shares $3.09 million -34.7%2.0%4 $5.40
12/15/2022875,700 shares $4.61 million +24.3%3.5%0.6 $5.27
11/30/2022704,700 shares $4.00 million -9.1%2.9%0.5 $5.68
11/15/2022775,600 shares $5.00 million -24.0%3.1%0.6 $6.45
10/31/20221,020,000 shares $7.06 million -23.3%4.2%0.8 $6.92
10/15/20221,330,000 shares $10.52 million -43.6%5.5%1 $7.91
9/30/20222,360,000 shares $23.67 million +238.1%9.7%1.8 $10.03
9/15/2022698,000 shares $4.31 million -0.3%2.9%6.2 $6.18
8/31/2022700,200 shares $3.98 million -32.0%2.9%5.1 $5.69
8/15/20221,030,000 shares $5.57 million +27.2%4.2%6.7 $5.41
7/31/2022809,900 shares $4.41 million -14.7%3.3%4.4 $5.44
7/15/2022949,400 shares $5.97 million -13.7%3.9%4.6 $6.29
6/30/20221,100,000 shares $5.17 million -45.5%4.5%4.8 $4.70
6/15/20222,020,000 shares $7.25 million -9.0%8.3%8.4 $3.59
5/31/20222,220,000 shares $7.86 million +11.0%9.1%10.1 $3.54
5/15/20222,000,000 shares $6.66 million +5.3%8.2%8.7 $3.33
4/30/20221,900,000 shares $7.33 million +5.0%7.8%7.9 $3.86
4/15/20221,810,000 shares $7.19 million +7.1%7.4%6.6 $3.97
3/31/20221,690,000 shares $6.61 million +47.0%6.9%6.5 $3.91
3/15/20221,150,000 shares $6.28 million +20.9%4.7%4.5 $5.46
2/28/2022951,600 shares $5.58 million +3.9%3.9%4.3 $5.86
2/15/2022916,000 shares $5.04 million -9.3%3.7%4.4 $5.50
1/31/20221,010,000 shares $5.17 million +4.3%4.7%5.4 $5.12
1/15/2022968,400 shares $5.21 million -4.1%3.5%7.6 $5.38
12/31/20211,010,000 shares $6.83 million +3.8%4.1%9.6 $6.76
12/15/2021973,200 shares $6.72 million +63.8%4.0%9.9 $6.90
11/30/2021594,000 shares $4.69 million -8.7%2.4%4.5 $7.90
11/15/2021650,300 shares $7.71 million -2.6%2.6%4.4 $11.85
10/29/2021667,700 shares $9.38 million -30.3%2.4%4.3 $14.05
10/15/2021958,100 shares $12.98 million +41.3%3.4%5.1 $13.55
9/30/2021677,900 shares $10.07 million +387.0%2.4%3.4 $14.86
9/15/2021139,200 shares $2.13 million +1,278.2%0.5%0.6 $15.33
8/31/202110,100 shares $180,992.00 +288.5%0.0%0 $17.92
8/13/20212,600 shares $39,442.00 No Change0.0%0 $15.17

ABOS Short Interest - Frequently Asked Questions

What is Acumen Pharmaceuticals' current short interest?

Short interest is the volume of Acumen Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 1,390,000 shares of ABOS short. 3.09% of Acumen Pharmaceuticals' shares are currently sold short. Learn More on Acumen Pharmaceuticals' current short interest.

What is a good short interest ratio for Acumen Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABOS shares currently have a short interest ratio of 7.0. Learn More on Acumen Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Acumen Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Acumen Pharmaceuticals: Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Acumen Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.09% of Acumen Pharmaceuticals' floating shares are currently sold short.

Is Acumen Pharmaceuticals' short interest increasing or decreasing?

Acumen Pharmaceuticals saw a decline in short interest in the month of November. As of November 30th, there was short interest totaling 1,390,000 shares, a decline of 5.4% from the previous total of 1,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Acumen Pharmaceuticals' float size?

Acumen Pharmaceuticals currently has issued a total of 60,080,000 shares. Some of Acumen Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acumen Pharmaceuticals currently has a public float of 45,030,000 shares.

How does Acumen Pharmaceuticals' short interest compare to its competitors?

3.09% of Acumen Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Acumen Pharmaceuticals: Monte Rosa Therapeutics, Inc. (23.93%), Esperion Therapeutics, Inc. (15.63%), Alpha Teknova, Inc. (2.68%), ChromaDex Co. (4.15%), Organogenesis Holdings Inc. (11.86%), Zevra Therapeutics, Inc. (8.12%), Verve Therapeutics, Inc. (28.32%), Arcturus Therapeutics Holdings Inc. (17.78%), Corvus Pharmaceuticals, Inc. (5.46%), SIGA Technologies, Inc. (9.13%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Acumen Pharmaceuticals stock?

Short selling ABOS is an investing strategy that aims to generate trading profit from Acumen Pharmaceuticals as its price is falling. ABOS shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acumen Pharmaceuticals?

A short squeeze for Acumen Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABOS, which in turn drives the price of the stock up even further.

How often is Acumen Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABOS, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:ABOS) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners